Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience

Abstract Background Cell-free and concentrated ascites reinfusion therapy (CART) is a strategy for improving various intractable symptoms due to refractory ascites, including hypoalbuminemia. CART has recently been applied in the treatment of cancer patients. This study was performed to assess the s...

Full description

Bibliographic Details
Main Authors: Misato Tsubokura, Yuko Adegawa, Minoru Kojima, Ryuji Tanosaki, Ryuzaburo Ohtake, Yuki Kase, Nao Iwashita, Moemi Kasane, Saori Nakabayashi, Sayaka Takeuchi, Ken Kato, Narikazu Boku, Yukihide Kanemitsu, Takuji Okusaka, Hiroyuki Fujimoto, Kan Yonemori, Hiroto Ishiki, Kimihiko Kawamura, Eriko Satomi, Hiromichi Matsushita
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Cancer
Subjects:
Cell-free and concentrated ascites reinfusion therapy (CART)
Malignant ascites
Adverse effects (AEs)
Fever
Reinfusion rate
Online Access:https://doi.org/10.1186/s12885-022-09298-6

Internet

https://doi.org/10.1186/s12885-022-09298-6

Similar Items